FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19840811000001107: Xarelto 15mg tablets (Bayer Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Jan 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66911901000001110 Xarelto 15mg tablets (Bayer Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66912001000001119 Xarelto 15mg tablets (Bayer Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xarelto 15mg tablets (Bayer Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) Is a Rivaroxaban 15mg tablets true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) Has active ingredient Rivaroxaban true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) Has specific active ingredient Rivaroxaban true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) Has excipient Lactose false Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) Is a Xarelto true Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xarelto 15mg tablets (Bayer Plc) 28 tablet 2 x 14 tablets Has AMP True Xarelto 15mg tablets (Bayer Plc) Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 42 tablet 3 x 14 tablets Has AMP True Xarelto 15mg tablets (Bayer Plc) Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 100 tablet 10 x 10 tablets Has AMP True Xarelto 15mg tablets (Bayer Plc) Inferred relationship Existential restriction modifier
Xarelto 15mg tablets (Bayer Plc) 14 tablet Has AMP True Xarelto 15mg tablets (Bayer Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start